Reza Farokhpay, M.D
Psychiatry Physician in Santa Ana, California.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 53,171 in Psychiatry Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
What the federal data shows
Reza Farokhpay, M.D reported a CMS MIPS final score of 100/100 - above the 83.5 national average - and filed 171 Medicare Part D claims in 2023.
- 100/100
- MIPS score · +17 vs avg
- 171
- Part D claims, 2023
- Likely
- board-certified (heuristic)
- ≥92nd
- pct among measured MIPS (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
CMS NPPES provider registry desk
NPI 1184829848 · Psychiatry Physician
NPI-10 · ENUM-MID · TAX-MEGA · MIPS-ELITE · RX-LIGHT · BOOK-MID · PHOTO-FINISH
- NPI-10 1184829848
- ENUM-MID 2007
- TAX-MEGA 53K Psychiatry Physician
- MIPS-ELITE 100/100
- RX-LIGHT 171
- BOOK-MID 7,700 in California
- PHOTO-FINISH Tariq Abbasi · ±0.0
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Farokhpay · this…
Farokhpay · this provider
100 MIPS pts
- Curtis Adams · h…
Curtis Adams
100 MIPS pts
- Tariq Abbasi · n…
Tariq Abbasi
100 MIPS pts
- Nicholas Abbey ·…
Nicholas Abbey
100 MIPS pts
- Eric Achtyes · n…
Eric Achtyes
100 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Reza Farokhpay, M.D's MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
100 ≥ 92nd percentile 92% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Reza Farokhpay, M.D sits
This provider among psychiatry physician peers
Across the 4,541 psychiatry physician providers who report both Medicare Part D prescribing and a MIPS quality score, Reza Farokhpay, M.D writes more Part D claims than 36% of them and scores higher on MIPS quality than 92% - placing this provider in the lower-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one psychiatry physician peer from a representative sample of 60; the gold marker is Reza Farokhpay, M.D. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
Reza Farokhpay, M.D practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Reza Farokhpay, M.D?
High performer (top quartile)Primary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in California
How Psychiatry Physician compares to other specialties among California providers
Psychiatry Physician ranks #30 among California's specialties (0.8% of in-state providers)
Each bar is a specialty's share of the California provider total, by primary NUCC taxonomy. The highlighted bar is Psychiatry Physician; the long tail of smaller specialties is omitted for legibility.
Medicare quality performance, MIPS
Reza Farokhpay, M.D's 2023 MIPS final score plotted against the Psychiatry Physician national average
- MIPS Final Score
- 100/100
- vs 83.5 national avg · 2023 performance year
Quality benchmarks
- National MIPS avg 2023 measured reporting year
- Quality dim CMS Quality category
- Specialty volume Psychiatry Physician US NPIs
100/100 MIPS final score - 16.5 pts above the 83.5 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Psychiatry Physician. Quality dim: 82.4.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1184829848 |
|---|---|
| Specialty | Psychiatry Physician |
| Credentials | M.D |
| Gender | Male |
| NPI Issued | 06/20/2007 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Reza Farokhpay, M.D's current license status, disciplinary history, and board certifications with the Medical Board of California in California before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1184829848 is the unique 10-digit identifier CMS uses to link Farokhpay across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Alternative Payment Model
Hospital and facility affiliations
Facilities where Reza Farokhpay, M.D bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
License & disciplinary context - California MBC 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 - they are NOT specific to Reza Farokhpay, M.D. To verify Reza Farokhpay, M.D's current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 174
- Total Day Supply
- 4,535
- Generic Drug Cost
- $5K
Patient Demographics
- Average Patient Age
- 46.5 years
- Avg HCC Risk Score
- 1.33
- Gender Split
- 42% female / 58% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Reza Farokhpay, M.D prescribes most
Top Medicare Part D drugs by claim count, 2023
- Lorazepam
Lorazepam
19 claims
- Clozapine
Clozapine
16 claims
- Olanzapine
Olanzapine
15 claims
- Alprazolam
Alprazolam
14 claims
- Sertraline Hcl
Sertraline Hcl
13 claims
- Risperidone
Risperidone
12 claims
- Escitalopram Oxalate
Escitalopram Oxalate
11 claims
| Drug | Claims |
|---|---|
| Lorazepam | 19 |
| Clozapine | 16 |
| Olanzapine | 15 |
| Alprazolam | 14 |
| Sertraline Hcl | 13 |
| Risperidone | 12 |
| Escitalopram Oxalate | 11 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Psychiatry Physician Overview
How Reza Farokhpay, M.D fits within the Psychiatry Physician landscape nationally.
Reza Farokhpay, M.D's 171 claims are below the specialty average of 1,038.
Nationwide Psychiatry Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Farokhpay, both outside California so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (100 here).
Same NPPES enumeration year (2007)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Psychiatry Physician Providers in California
Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as Farokhpay.
One of 7,700 Psychiatry Physician providers enrolled in California, 5 are shown here.
Compare Psychiatry Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Reza Farokhpay, M.D's specialty? ▼
How much does Reza Farokhpay, M.D prescribe under Medicare Part D? ▼
What is Reza Farokhpay, M.D's Medicare quality score? ▼
Where is Reza Farokhpay, M.D located? ▼
What is Reza Farokhpay, M.D's NPI number? ▼
How many Psychiatry Physician providers are there in the US? ▼
What drugs does Reza Farokhpay, M.D prescribe most often? ▼
Does Reza Farokhpay, M.D accept Medicare? ▼
How can I verify Reza Farokhpay, M.D's credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.
Published by
PlainDoctor
Independent public-data reference that compiles, verifies, and contextualizes official datasets. We do not accept compensation from entities we cover, and every dataset cites its originating public source.